AWM Investment Company’s Eterna Therapeutics ERNA Stock Holding History

AWM Investment Company’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19	Closed	-$1.27M	–	88
2018 Q3	$1.27M	Hold	19	–	–	0.21%	77
2018 Q2	$1.27M	Buy	19 +2	+12%	+$145K	0.21%	74
2018 Q1	$1.71M	Sell	17 -2	-11%	-$168K	0.33%	66
2017 Q4	$1.21M	Sell	19 -2	-10%	-$158K	0.24%	80
2017 Q3	$1.91M	Sell	21 -1	-5%	-$104K	0.33%	66
2017 Q2	$2.2M	Hold	22	–	–	0.39%	59
2017 Q1	$2.79M	Hold	22	–	–	0.52%	53
2016 Q4	$2.76M	Buy	22 +10	+83%	+$1.2M	0.54%	55
2016 Q3	$1.24M	Hold	12	–	–	0.23%	78
2016 Q2	$1.56M	Hold	12	–	–	0.33%	66
2016 Q1	$1.36M	Hold	12	–	–	0.29%	68
2015 Q4	$1.45M	Hold	12	–	–	0.29%	68
2015 Q3	$2.92M	Hold	12	–	–	0.56%	52
2015 Q2	$2.11M	Buy	12 +1	+9%	+$259K	0.3%	81
2015 Q1	$3.42M	Buy	11 +1	+10%	+$354K	0.47%	70
2014 Q4	$3.44M	Buy	+10	New	+$2.77M	0.47%	66

Other funds holding ERNA

NSIM

North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Callahan Advisors Houston, Texas $1.33B AUM 29.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWM Investment Company's ERNA Position: Q4 2018 in Review

AWM Investment Company sold out of Eterna Therapeutics (ERNA) in Q4 2018, closing a stake of 19 shares — an estimated $1.27M sold.

AWM Investment Company first reported a position in ERNA in Q4 2014 and held it in 16 quarters. The position peaked at $3.44M in Q4 2014. 6 funds tracked by Wall St. Rank hold ERNA as of Q4 2018.

AWM Investment Company reported no remaining Eterna Therapeutics position as of Q4 2018 after selling out during the quarter.
AWM Investment Company sold 19 Eterna Therapeutics shares in Q4 2018, an estimated $1.27M.
AWM Investment Company first reported a position in Eterna Therapeutics in Q4 2014 and held it in 16 quarters.
AWM Investment Company's Eterna Therapeutics position peaked at $3.44M in Q4 2014.
6 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2018.

Based on AWM Investment Company's 13F filing for Q4 2018, filed 13 Feb 2019.